Investors

31 October 2024

Invitation to attend presentation

→

30 October 2024

Archer’s 12CQ Quantum Project Hits Key Milestone

→

23 October 2024

Semiconductor Australia Conference - Presentation

→

18 October 2024

Notice of Annual General Meeting/Proxy Form

→

14 October 2024

Departure of CEO (update)

→

10 October 2024

Agreement signed with foundry to manufacture TMR sensors

→

04 October 2024

Quarterly Activity Report & Appendix 4C

→

30 September 2024

Archer develops new manufacturable carbon quantum material

→

03 September 2024

Proof of concept devices to improve 12CQ chip spin detection

→

28 August 2024

Appendix 4E and 2024 Annual Report

→

28 August 2024

2024 Corporate Governance Statement and Appendix 4G

→

27 August 2024

Biochip experiments begin to develop kidney disease testing

→

16 August 2024

New Integrated biochip gFET to bolster functionality

→

26 July 2024

Quarterly Activity Report & Appendix 4C

→

23 July 2024

New Biochip gFET test procedure and process developed

→

18 July 2024

Quantum technology project update

→

15 July 2024

Management restructure

→

12 July 2024

Departure of CEO

→

28 June 2024

Notification of cessation of securities - AXE

→

17 June 2024

Archer Biochip gFET design fabricated on a six-inch wafer

→